In order to access the Stocks Valuation, please log on to your TD Ameritrade account or open an account!
Madrigal Pharmaceuticals IncChange company Symbol lookupSelect an option...MDGL Madrigal Pharmaceuticals IncEMUSF Electric Metals USA LtdINPX InpixonHUBC Hub Cyber Security LtdPTON Peloton Interactive IncPIXY ShiftPixy IncBCAN BYND Cannasoft Enterprises IncGLTO Galecto IncERNA Eterna Therapeutics IncTANH Tantech Holdings LtdGo
Change company Symbol lookup
Select an option...
MDGL Madrigal Pharmaceuticals Inc
EMUSF Electric Metals USA Ltd
INPX Inpixon
HUBC Hub Cyber Security Ltd
PTON Peloton Interactive Inc
PIXY ShiftPixy Inc
BCAN BYND Cannasoft Enterprises Inc
GLTO Galecto Inc
ERNA Eterna Therapeutics Inc
TANH Tantech Holdings Ltd
Health Care : Biotechnology | Small Cap Value
Company profileMadrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a proprietary, liver-directed, selective thyroid hormone receptor-B (THR-B), agonist being developed as a once-daily oral pill for the treatment of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). NASH is a liver disease that affects people with metabolic diseases, such as obesity and diabetes and non-alcoholic fatty liver disease (NAFLD).
|
|
|
|
| |
Please Log On
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.
Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.